Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences has excelled in the last Research Excellence Framework (REF) results.

The Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences has excelled in the last Research Excellence Framework (REF) results.

The REF assesses the quality and impact of research submitted by universities across all disciplines, with the latest results showing top-ranking for Oxford’s clinical medicine.

NDORMS submitted to the REF’s Unit of Assessment 1 - Clinical Medicine - alongside other academic departments, and contributed significantly to the excellent results of UoA1 at Oxford; the sub-panel welcomed the strong return in orthopaedic sciences, as well as the outstanding reach and significance of the impacts from research in musculoskeletal and ageing.

Professor Andrew Carr, Head of NDORMS, said: "NDORMS has made a significant contribution to the nationally top ranked submission from the University of Oxford. It is particularly gratifying to have been specifically mentioned by the assessment panel for both the quality of our publications and the impact of our research. This is a testament to the world class multidisciplinary researchers working in the department."

The results for UoA1 show Clinical Medicine at Oxford ranked top on overall REF research profile (GPA rank) using all quality scores. Overall, we were also top ranked with maximum 4* score, where 53% of overall submissions were judged to be world-leading for originality, significance and rigour, and 92% of our overall quality profile was rated as ‘world leading’ or ‘internationally excellent’. On addition, 82% of our research impacts were scored 4* - outstanding in terms of reach and significance - and 18% scored 3*.

You can see an example of how research at NDORMS significantly impacts people’s lives in this short video on fighting arthritis.

Read more on the University’s page and see the University's REF 2014 results table.

Similar stories

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Patients like me

What can patients learn from the experiences of people like them who’ve already had a hip replacement? A new tool called ‘Patients like me’ helps answer some of the questions about pain, complications and how long the prosthesis might last.

Study reveals new evidence on rare blood-clotting condition after covid-19 vaccination

Researchers from NDORMS at the University of Oxford have investigated claims that some adenovirus-based COVID-19 vaccines increase the risk of rare blood clots compared to their mRNA-based counterparts.

NDORMS contributes to new UK research to tackle monkeypox outbreak

The UK’s efforts to tackle the monkeypox outbreak will receive a huge boost with the creation of a new research consortium and a new study to study vaccine effectiveness.

World Osteoporosis Day 2022

A bone-healthy lifestyle is vital for strong bones and a mobile, fracture-free future. On World Osteoporosis Day, we are sharing advice from the International Osteoporosis Foundation (IOF), on putting your bone health first.

Mathematician boosts data science research at the Kennedy Institute

Welcome to Yang Luo who has joined the Kennedy Institute as the Principal Investigator of the Luo Group. Her lab is leading the investigation into how genetic variations contribute to diseases of the immune system.